T Cell News and Research

Latest T Cell News and Research

Athletic trainers and coaches bear major responsibility for preventing deaths

Colleges and high schools must follow an active strategy to preventing deaths among student athletes from exertional heat stroke (EHS) and other causes, according to an editorial in a recent issue of The Journal of Strength and Conditioning Research, official research journal of the National Strength and Conditioning Association.

27 Jul 2011

Novel blood-cleaning procedure allows receipt of transplant from different blood type donor

St. Michael's Hospital today became the first in North America to use a novel blood-cleaning procedure for a kidney patient that will allow him to receive a transplant from a donor with a different blood type.

27 Jul 2011

New silicone chip could make genetic analysis far more sensitive, rapid, and cost-effective

UBC researchers have invented a silicone chip that could make genetic analysis far more sensitive, rapid, and cost-effective by allowing individual cells to fall into place like balls in a pinball machine.

27 Jul 2011

Lipofilling found safe after breast cancer surgery

Preliminary experience suggests that lipofilling—using fat from elsewhere in the patient's body for contouring of the breasts—is a safe procedure for women who have undergone breast cancer surgery, reports a study in the August issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).

27 Jul 2011

Study suggests common process for both pleasurable and anxiety-reducing effects of nicotine

Removing a protein from cells located in the brain's reward center blocks the anxiety-reducing and rewarding effects of nicotine, according to a new animal study in the July 27 issue of The Journal of Neuroscience. The findings may help researchers better understand how nicotine affects the brain.

27 Jul 2011

Early initiation of HIV therapy would save money, lives of South Africans

If the South African government followed a recent recommendation by the World Health Organization to start antiretroviral therapy (ART) for HIV-infected residents earlier in the progress of the disease, the policy shift would start saving the country money after 16 years and would extend thousands of lives for dozens of years, according to a new study.

27 Jul 2011

Lipid-based nanocarrier can improve cancer treatments

Scientists seeking to improve cancer treatments have created a tiny drug transporter that maximizes its ability to silence damaging genes by finding the equivalent of an expressway into a target cell.

27 Jul 2011

New preclinical data suggests microRNA-15 inhibits cardiomyogenesis

miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, announced today that new preclinical data published in the online edition of Circulation Research suggests that microRNA-15 (miR-15) inhibits cardiomyogenesis, the process whereby new heart muscle cells are formed.

27 Jul 2011

Health Canada issues notice of compliance for OCPI's SAMSCA to treat hyponatremia

Otsuka Canada Pharmaceutical Inc. (OCPI) announced today that Health Canada has issued a notice of compliance for SAMSCA (tolvaptan), the first medicine approved in Canada for the treatment of hyponatremia.

27 Jul 2011

Anavex presents data on neuroprotective evidence for lead compound for Alzheimer’s

Anavex Life Sciences Corp. is pleased to provide a summary of its second poster presentation at the Alzheimer’s Association International Conference (AAIC) held in Paris, entitled “Preclinical development of new tetrahydrofuran derivatives targeting the sigma-1 chaperone protein as neuroprotectants in Alzheimer’s disease.”

26 Jul 2011

Selexis, CSL enter commercial license agreement for therapeutic antibody

Selexis SA, a global life science company with technologies for drug discovery, cell line development and scale-up to manufacturing of therapeutic proteins announced today that CSL Limited has entered a commercial license agreement with Selexis for the preclinical development of a therapeutic antibody anticipated to enter Phase I clinical trials in 2012.

26 Jul 2011

Kadmon, Dyax enter license agreement for antibody phage display libraries

Dyax Corp. and Kadmon Corporation, LLC announced today that Dyax has granted Kadmon a non-exclusive license to Dyax's proprietary "gold-standard" antibody phage display libraries for the discovery and development of therapeutic antibodies.

26 Jul 2011

Substances found in cigarette smoke damage blood vessels' endothelial cells

A research term headed by David Bernhard from the University Department of Surgery at the Medical University of Vienna has found out that substances found in cigarette smoke lead to blood vessels' endothelial cells constantly digesting themselves.

26 Jul 2011

Late-stage prostate tumors are driven by different hormonal pathway

UT Southwestern Medical Center researchers have narrowed the potential drug targets for advanced prostate cancer by demonstrating that late-stage tumors are driven by a different hormonal pathway than was thought previously.

26 Jul 2011

BioWa, arGEN-X sign license agreement for POTELLIGENT Technology

arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody platform, announces it has signed a non-exclusive license agreement with BioWa Inc., the exclusive worldwide licensor of POTELLIGENT Technology.

26 Jul 2011

TikoMed receives FDA Orphan Drug Designation for TM-400 to treat hematological cancers

TikoMed AB, a biotechnology company focused on the development and commercialization of innovative treatments of immune diseases and transplantation therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted TM-400 Orphan Drug Designation for the mobilization of stem cells prior to stem cell transplantation treatment.

26 Jul 2011

Majority of parents unaware of medical research participation opportunities for children

One in nine adults have participated in medical research. In contrast, only one in 20 children have done so. Those are the findings of a poll earlier this year by the University of Michigan C.S. Mott Children's Hospital National Poll on Children's Health. The poll asked adults and parents about their views on medical research and past participation for themselves and their children.

26 Jul 2011

Symposium papers highlight role of oxidative stress in cardiovascular disease

Recent years have seen major advances in understanding of the health effects of oxidative stress—including its potential to cause injury to the cardiovascular system. A series of expert updates on the role of oxidative stress in heart failure, atherosclerosis, and other cardiovascular diseases appears in a special symposium in the August issue of The American Journal of the Medical Sciences, official journal of the Southern Society for Clinical Investigation.

26 Jul 2011

New potential anti-tumor agents might effectively treat mesothelioma

Researchers from the lab of Antonio Giordano, M.D., Ph.D., the Founder and Director of the Sbarro Institute for Cancer Research and Molecular Medicine, have identified new potential anti-tumor agents that might be effective in treating mesothelioma, one of the deadliest cancer tumors.

26 Jul 2011

GCMS, PBS Biotech sign distribution agreement for single-use bioreactors in Korea

PBS Biotech, Inc., a developer of state of the art single-use bioreactors for the fast growing biotechnology market, announced today it has signed an exclusive distribution agreement in Korea with Green Cross Medical Sciences Corp. (GCMS), a division of Green Cross Corporation, one of Korea's largest pharmaceutical firms.

26 Jul 2011

T Cell News and Research

Latest T Cell News and Research

Athletic trainers and coaches bear major responsibility for preventing deaths

Novel blood-cleaning procedure allows receipt of transplant from different blood type donor

New silicone chip could make genetic analysis far more sensitive, rapid, and cost-effective

Lipofilling found safe after breast cancer surgery

Study suggests common process for both pleasurable and anxiety-reducing effects of nicotine

Early initiation of HIV therapy would save money, lives of South Africans

Lipid-based nanocarrier can improve cancer treatments

New preclinical data suggests microRNA-15 inhibits cardiomyogenesis

Health Canada issues notice of compliance for OCPI's SAMSCA to treat hyponatremia

Anavex presents data on neuroprotective evidence for lead compound for Alzheimer’s

Selexis, CSL enter commercial license agreement for therapeutic antibody

Kadmon, Dyax enter license agreement for antibody phage display libraries

Substances found in cigarette smoke damage blood vessels' endothelial cells

Late-stage prostate tumors are driven by different hormonal pathway

BioWa, arGEN-X sign license agreement for POTELLIGENT Technology

TikoMed receives FDA Orphan Drug Designation for TM-400 to treat hematological cancers

Majority of parents unaware of medical research participation opportunities for children

Symposium papers highlight role of oxidative stress in cardiovascular disease

New potential anti-tumor agents might effectively treat mesothelioma

GCMS, PBS Biotech sign distribution agreement for single-use bioreactors in Korea

Immunology eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in